The head of the Egyptian Medicines Agency is discussing with “Nofarts” plans to expand manufacturing and increase exportation

عقد الدوكتر علي الغمراوي, رعيس الحياس الدواع المصرى, official meeting with وفدة شركة نوفارتس in order to strengthen cooperation Strategic with major international pharmaceutical companies, contributing to the development of the pharmaceutical industry and supporting the national economy.

The meeting discussed the performance of the Nofarts company in the Egyptian market, and its future plans for the expansion of production lines and the introduction of special products. بالشركة, هذا عقدت الشركة على تفريق على قطعة عدوية لسوقين المصري والقرآني.

During the meeting, Dr. Ali al-Ghamrawi confirmed his desire to continue cooperation with the manufacturing companies, and to introduce all of them Because of the possible support for the development of the national industrial sector, it reflects the importance of this vital sector in the support of the national economy and strengthening the capabilities of Egypt in the field of health care, in addition to the importance of expanding local production to reduce dependence on imports, and increasing export opportunities for regional and international markets, contributing to enhancing the competitiveness of the Egyptian pharmaceutical product and achieving profitability self امر دهي ينقوس إيجابً على صحة الموطنة ويدعم الدولة فيلمة في هذا قصرة الستراجيك.

He pointed out that the organization works continuously to update the working mechanisms and procedures in accordance with international standards, with the aim of stimulating Investment in the world of medicine, and the latest manufacturing technologies in Egypt.

On their part, the Arab representatives of the Nofarts company express their deep appreciation for the important role played by the Egyptian medical authority in supporting the industry. الدوائيا وتذليل العقبة اما عام الدوائية, مشيدين بشيدين بشيرة على على على على على على على على على على على على على على على على على المعادنة المحمولة المحمولة وتعليم العقبة اماء بيحة The flexible and sophisticated organization contributes to increasing production and supporting export plans, which benefits the Egyptian patient and the regional markets. except that

Share in the meeting on the side of the Egyptian Medicines Authority, Dr. Amani Joudt, Assistant Head of the Authority and Supervisor of the Central Administration لمكتب رياس درائمة, والدكتور اسامة حتم, إثاثير رياضي لشعون للشعون والتاوبون الدولينيا والمشرف على درامهاء المركزية للصياحة الدوائية ودعم الموقع

From the side of the company Nofarts, Dr. Jehan Al-Mar, Chairman of the Board of Directors and Managing Director, and Dr. Rania Ashraf, Head of the Sector Government Relations in the Middle East, Dr. Omar Nasr, Head of External Relations Sector, Dr. Najla Fathi, Head of Department registration بالشركة.

This comes in the framework of the active partnership between the Authority and the pharmaceutical industry, with the aim of ensuring the availability of safe and effective medicine for the Egyptian patient, and strengthen the competitiveness of local pharmaceutical products in foreign markets, with a qualitative shift in the level of local manufacturing according to the latest international quality standards.